A Day Up For Immuron Limited
Mon, May 08, 2023 at 08:17 PM
Immuron Limited (IMRN:NASDAQ) soared at $2.68, representing a gain of 43.3%. On Mon, May 08, 2023, IMRN:NASDAQ hit a New 2-Week High of $2.68. The stock appeared on our News Catalysts scanner on Mon, May 08, 2023 at 05:09 PM in the 'BIOTECH' category. From Mon, Apr 24, 2023, the stock recorded 30.00% Up Days and 27.27% Green Days
About Immuron Limited (IMRN:NASDAQ)
Immuron Ltd is a biopharmaceutical company which develops polyclonal antibodies for the treatment and prevention of diseases. It products include Travelan, IMM-124E for NASH and IMM-529 for Clostridium difficile infection.
Top 10 Gainers:
- Trevena, Inc. (TRVN:NASDAQ), 382.25%
- Ohmyhome Limited (OMH:NASDAQ), 328.71%
- Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ), 146.15%
- Acorda Therapeutics, Inc. (ACOR:NASDAQ), 77.78%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 75.6%
- JE Cleantech Holdings Limited (JCSE:NASDAQ), 59.74%
- MoneyLion Inc. Class A (ML:NYSE), 49.92%
- Immuron Limited (IMRN:NASDAQ), 43.32%
- VivoPower International PLC (VVPR:NASDAQ), 41.7%
- Lightning eMotors Inc (ZEV:NYSE), 39.47%